Poor Responses to a Test Dose of Subcutaneous Octreotide Predict the Need for Adjuvant Therapy to Achieve 'Safe' Growth Hormone Levels

Author： Lindsay J.   McConnell E.   Hunter S.   McCance D.   Sheridan B.   Atkinson A.  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.7, Iss.3, 2004-10, pp. : 139-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET**

By Fouda Usama M.   Sayed Ahmed M.  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 1018-1022

Informa Healthcare

Access to resources Recommend Favorite

Growth Hormone Therapy in Adults

By Conceicao F.L.   Bojensen A.   Lunde Jorgensen J.O.   Christiansen J.S.  

Frontiers in Neuroendocrinology, Vol. 22, Iss. 3, 2001-07 ,pp. : 213-246

Elsevier

Access to resources Recommend Favorite

Growth Hormone Therapy for Adult Growth Hormone Deficiency

By Shalet S.M.   Rahim A.   Toogood A.A.  

Trends in Endocrinology and Metabolism, Vol. 7, Iss. 8, 1996-10 ,pp. : 287-290

Elsevier

Access to resources Recommend Favorite

Daily Low-Dose Administration of Growth Hormone Secretagogue Stimulates Pulsatile Growth Hormone Secretion and Elevates Plasma Insulin-like Growth Factor-1 Levels in Pigs

By Malmlöf K.   Bauer M.K.   Ankersen M.   Johansen P.B.   Veldhuis J.D.  

Endocrine Journal, Vol. 16, Iss. 3, 2001-12 ,pp. : 195-200

Humana Press, Inc

Access to resources Recommend Favorite

The Somatopause: An Indication for Growth Hormone Therapy?

By Toogood Andrew A.  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 201-209

Adis International

Access to resources Recommend Favorite